[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361375-105":59,"doc-detail-361375-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","thiostrepton-potentiates-chemotherapy-induced-cell-death-in-cisplatin-resistant-skov3-cells","Thiostrepton potentiates chemotherapy-induced cell death in cisplatin-resistant SKOV3 cells","","Thiostrepton (TST), a thiazole antibiotic, is evaluated as a sensitizer for cisplatin in the SKOV3/CDDP cisplatin-resistant ovarian cancer model. The study tests TST and cisplatin alone and in combination, then measures viability, intracellular energy, membrane damage, apoptosis markers (caspase-3/7 and TUNEL), and DNA damage (Comet and CBMN). Combination treatment increases oxidative stress, DNA damage, and inflammatory cytokines while lowering antioxidant defenses and reducing c-MYC/AXIN2 expression, attenuating β-catenin-dependent transcription. Overall, TST enhances cisplatin sensitivity through oxidative-mitochondrial stress, genotoxicity, and reduced Wnt/β-catenin signaling.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/thiostrepton-potentiates-chemotherapy-induced-cell-death-in-cisplatin-resistant-skov3-cells/361375/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/thiostrepton-potentiates-chemotherapy-induced-cell-death-in-cisplatin-resistant-skov3-cells/361375.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in ovarian cancer treatment?","Question",{"text":112,"@type":113},"The study targets cisplatin resistance, a major obstacle that reduces the effectiveness of platinum-based chemotherapy in ovarian cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were TST and cisplatin evaluated in the experiments?",{"text":117,"@type":113},"SKOV3/CDDP resistant cells were treated with cisplatin (IC50), TST at 1–5 µM, or the combination for 24 hours, and multiple cellular outcomes were measured.",{"name":119,"@type":110,"acceptedAnswer":120},"What key effects did the cisplatin + TST combination produce?",{"text":121,"@type":113},"The combination was more potent than either agent alone, increasing oxidative stress and DNA damage, elevating inflammatory cytokines, reducing antioxidant capacity, and decreasing c-MYC and AXIN2 expression with attenuation of β-catenin-dependent transcription.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361375,1790192621,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Motafeghi etal. BMC Cancer (2026) 26:1034 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-16376-6](https://doi.org/10.1186/s12885-026-16376-6)  \nRESEARCH Open Access  \nThiostrepton potentiates chemotherapy- induced cell death in cisplatin-resistant SKOV3 cells  \nFarzaneh Motafeghi 1, Ehsan Ghassemi Barghi2,3, Jafar Gholami Gharab3, Parham Mortazavi4, Fahimeh Ramezani Tehrani1, Sorour Ashari5* and Nasrin Ghassemi Barghi3,6*  \nAbstract  \nBackground One of the main problems in the treatment of ovarian cancer is resistance to the main drug (cisplatin) . Thiostrepton (TST), a thiazole antibiotic, helps weaken cancer cells and enhance the efficacy of platinum-based therapy. This study examines the combination ofTST and cisplatin in the SKOV3/CDDP model of resistance, focusing on associated changes in oxidative stress, mitochondrial function, genotoxicity, apoptosis, inflammatory mediators, and Wnt/β-catenin output.  \nMethods SKOV3/CDDP cells were treated with cisplatin at an IC50 concentration, TST at concentrations (1, 2 . 5, 5 µM), and the combination of these two substances for 24 h. Cell viability, intracellular energy, and membrane damage were measured by MTT and ATP assays and LDH release, respectively. Apoptosis was assessed using caspase-3/7 and TUNEL activity. DNA damage was analyzed using the Comet and CBMN assays. Oxidative stress and antioxidant defense were assessed by measuring ROS, MDA, GSH/GSSG ratio, and SOD, catalase, and GPx activities. Mitochondrial dysfunction (ΔΨm, NAD+/NADH), cytokines (IL-6, IL-8, TNF-α, IL-1β), and Wnt/β-catenin target genes (c-MYC, AXIN2)  \nwere evaluated.  \nResults The combination of cisplatin and TST was much more potent than when either was used alone. This combination increased oxidative stress processes, increased DNA damage, and decreased antioxidant capacity in cancer cells. Inflammatory cytokine levels were also increased, and c-MYC and AXIN2 expression were reduced, which was accompanied by the attenuation of β-catenin-dependent transcription.  \nConclusion Overall, TST increased the sensitivity of resistant ovarian cancer cells to cisplatin. Its anticancer effect was enhanced by oxidative-mitochondrial stress and DNA damage pathways, along with reduced Wnt/β-catenin transcription.  \nKeywords Cisplatin, Thiostrepton, Chemoresistance, Drug resistance, Ovarian cancer, SKOV3  \n*Correspondence:  \nSorour Ashari[sorour.ashari424@gmail.com](sorour.ashari424@gmail.com)[ ](sorour.ashari424@gmail.com)Nasrin Ghassemi Barghi[ngeternal67@yahoo.com](ngeternal67@yahoo.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nMotafeghi et al. BMC Cancer (2026) 26:1034 Page 2 of 19  \nGraphical Abstract  \nIntroduction  \nOvarian cancer is a clinical challenge for women worldwide. Mortality from this cancer is associated with various factors, including the","cbCaij3TbFFgnDLl","https://ap.wps.com/l/cbCaij3TbFFgnDLl","pdf",4050806,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What problem does the study address in ovarian cancer treatment?\",\"answer\":\"The study targets cisplatin resistance, a major obstacle that reduces the effectiveness of platinum-based chemotherapy in ovarian cancer patients.\"},{\"question\":\"How were TST and cisplatin evaluated in the experiments?\",\"answer\":\"SKOV3/CDDP resistant cells were treated with cisplatin (IC50), TST at 1–5 µM, or the combination for 24 hours, and multiple cellular outcomes were measured.\"},{\"question\":\"What key effects did the cisplatin + TST combination produce?\",\"answer\":\"The combination was more potent than either agent alone, increasing oxidative stress and DNA damage, elevating inflammatory cytokines, reducing antioxidant capacity, and decreasing c-MYC and AXIN2 expression with attenuation of β-catenin-dependent transcription.\"}]","Thiostrepton potentiates chemotherapy-induced cell death in cisplatin-resistant SKOV3 cells | PDF",1790144103,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a75b26dd2355ff318793476ffa8b2c2.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2aadc1dc1ae62cf33d4213b9b75082df.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b19e427be137352374db99ccc7e03d94.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b5e2c0aeccb2c43a2121bb91ae69b10.webp",980,1306]